Clinical Scorecard: Case Study of Polymorphous Low-Grade Neuroepithelial Tumor in a Young Patient

At a Glance

Key Highlights

• Patient presented with a 6-year history of drug-resistant epilepsy.
• 30-year-old male; MRI showed an ovoid area of abnormal signal in the left temporal pole.
• Pathological examination confirmed PLNTY, CNS WHO Grade 1.
• Postoperative outcome included complete seizure control.
• Molecular testing revealed BRAF mutation positivity.

Guideline-Based Recommendations

Diagnosis

• Integration of clinical history, imaging (including MRI), pathological morphology, immunohistochemistry, and molecular testing.

Management

Monitoring & Follow-up

Risks

Patient & Prescribing Data

Surgical intervention leads to favorable prognosis and seizure control, with most patients achieving significant reduction in seizure frequency.

Clinical Best Practices

• Consider PLNTY in young patients with drug-resistant epilepsy and atypical imaging findings.
• Utilize comprehensive diagnostic approaches including imaging and molecular testing, emphasizing the role of molecular testing.

Related Resources & Content

• WHO Classification of Tumors of the Central Nervous System
• Huse JT et al., 2016